Results 101 to 110 of about 218,065 (393)

cAMP- and cGMP-elevating agents inhibit GPIbα-mediated aggregation but not GPIbα-stimulated Syk activation in human platelets

open access: yesCell Communication and Signaling, 2019
Background The glycoprotein (GP) Ib-IX-V complex is a unique platelet plasma membrane receptor, which is essential for platelet adhesion and thrombus formation.
Stephanie Makhoul   +6 more
doaj   +1 more source

Generic versus brand-name drugs used in cardiovascular diseases [PDF]

open access: yes, 2016
This meta-analysis aimed to compare the efficacy and adverse events, either serious or mild/moderate, of all generic versus brand-name cardiovascular medicines.
Boccia, Stefania   +9 more
core   +1 more source

Characterization and cDNA Cloning of a Platelet Aggregation Inhibitor

open access: yesMolecules and Cells, 2000
A novel platelet aggregation inhibitor, sal-C, was purified to homogeneity from the venom of Korean snake (Agkistrodon halys brevicaudus). Several lines of experimental evidence clearly indicated that sal-C inhibits not only the collagen-induced platelet aggregation, but also the aggregation mediated by the cell surface glycoprotein IIb-IIIa (GP IIb ...
Y S, Koh, D S, Kim
openaire   +2 more sources

Smart, Bio‐Inspired Polymers and Bio‐Based Molecules Modified by Zwitterionic Motifs to Design Next‐Generation Materials for Medical Applications

open access: yesAdvanced Functional Materials, EarlyView.
Bio‐based and (semi‐)synthetic zwitterion‐modified novel materials and fully synthetic next‐generation alternatives show the importance of material design for different biomedical applications. The zwitterionic character affects the physiochemical behavior of the material and deepens the understanding of chemical interaction mechanisms within the ...
Theresa M. Lutz   +3 more
wiley   +1 more source

Impact of acute exacerbations on platelet reactivity in chronic obstructive pulmonary disease patients

open access: yesInternational Journal of COPD, 2017
Mariana Muñoz-Esquerre,1 José Luis Ferreiro,2 Daniel Huertas,1,3 Ana Lucrecia Marcano,2 Marta López-Sánchez,1 Gerard Roura,2 Joan Antoni Gómez-Hospital,2 Jordi Dorca,1 Angel Cequier,2 Salud Santos1,3 1Department of ...
Muñoz-Esquerre M   +9 more
doaj  

Acute Chest Pain—Diagnostic Accuracy and Pre-Hospital Use of Anticoagulants and Platelet Aggregation Inhibitors [PDF]

open access: yesDtsch Arztebl Int, 2023
Braumann S   +15 more
europepmc   +1 more source

Lipopolysaccharide as trigger of platelet aggregation via eicosanoid over-production [PDF]

open access: yes, 2017
The effect of lipopolysaccharide (LPS) on platelet aggregation is still controversial. We performed in vitro and ex vivo studies in controls and in patients with community-acquired pneumonia (CAP) to assess the effect of LPS on platelet activation (PA ...
Camilla Calvieri   +9 more
core   +1 more source

2,2'-Dithiodibenzamides as inhibitors of blood platelet aggregation.

open access: yesChemical and Pharmaceutical Bulletin, 1985
AbstractAus den 2,2′‐Dithiodibenzoesäuren (I) werden über die Säurechloride (II) drei Reihen von Dithiodibenzamiden hergestellt und auf inhibierende Wirkung bei der Blutplättchen‐ Aggregation untersucht.
Kazuhiro Kubo   +8 more
openaire   +5 more sources

Solvent‐Free Bonding Mechanisms and Microstructure Engineering in Dry Electrode Technology for Lithium‐Ion Batteries

open access: yesAdvanced Functional Materials, EarlyView.
Dry electrode technology revolutionizes battery manufacturing by eliminating toxic solvents and energy‐intensive drying. This work details two promising techniques: dry spray deposition and polymer fibrillation. How their unique solvent‐free bonding mechanisms create uniform microstructures for thicker, denser electrodes, boosting energy density and ...
Yuhao Liang   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy